Donald R. Miller, PharmD, professor and chair of pharmacy practice at North Dakota State University for 30 years, has been appointed to the U.S. Food and Drug Administration (FDA) Arthritis Advisory Committee for a three-year term.
The FDA Arthritis Advisory Committee meets two to three times per year. By law, the group gathers each time a new drug entity is considered for first-time approval or when advice is requested from a panel of experts.
Since 1994, Dr. Miller has been a faithful member of the ARHP. During his committee service, Dr. Miller served on the ACR Drug Safety Subcommittee and the ARHP Practice Committee. He believes that his service on ACR/ARHP committees led to his nomination on the FDA Arthritis Advisory Committee. Dr. Miller has always taught rheumatology and evidence-based medicine to pharmacy students. “I am very excited,” Dr. Miller said of his appointment. “I have found that evaluating the quality of drug studies is interesting and a perfect fit with my background, for serving on the FDA Arthritis Advisory Committee. I am looking forward to the work ahead.”
Dr. Miller earned his bachelor’s degree at the University of Manitoba and his Doctor of Pharmacy at the University of Michigan.
